Comparative effectiveness and safety of vancomycin versus linezolid for the treatment of central nervous system infections: a meta-analysis.

Front Cell Infect Microbiol · 2025 · PMC12488671 · PMID 41050758

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

(2016) reported a nonsignificant trend favoring linezolid (SMD = 0.29, 95% CI: -0.18 to 0.76).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.